The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of outcomes in patients (pts) with relapsed/refractory acute promyelocytic leukemia (APL) treated with and without high-dose chemotherapy and hematopoietic stem cell transplantation (HCT).
N. Pemmaraju
No relevant relationships to disclose
F. Ravandi
No relevant relationships to disclose
G. Rondon
No relevant relationships to disclose
S. Giralt
No relevant relationships to disclose
J. Chen
No relevant relationships to disclose
S. Pierce
No relevant relationships to disclose
R. E. Champlin
No relevant relationships to disclose
M. De Lima
No relevant relationships to disclose
M. Qazilbash
No relevant relationships to disclose